Medicine details

ImageMefoglip 2.5/500
NameMefoglip 2.5/500
DosageTablet
Generic NameGlipizide + Metformin Hydrochloride
Classes Antidiabetic Agent
Metabolic Agent
Antidiabetic combination
Diseases Type 2 Diabetes Mellitus
Hormonal Disorder
CompanyIncepta Pharmaceuticals Ltd.

Drug Package Details

Strength2.5 mg + 500 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack30
Price per pack84.00
Cost per pack73.92
Package unit10 tabs strip
Price per unit2.80
Cost per unit2.46
Discount0
Coupon
Remarks

Glipizide + Metformin Hydrochloride

Glipizide + Metformin Hydrochloride is an antidiabetic combination of Glipizide & Metformin. Glipizide belongs to the sulfonylurea class of antidiabetic drugs. Glipizide is an insulin secretagogue which works by inhibiting K+ channels of beta cells and ultimately increasing the secretion of insulin. Metformin is a hypoglycemic agent belonging to the class Biguanides. Metformin enhances insulin sensitivity by boosting peripheral glucose uptake and utilization, decreasing hepatic glucose synthesis, and decreasing intestinal glucose absorption.

Glipizide + Metformin Hydrochloride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

Dosage of METAGLIP must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended daily dose of 20 mg glipizide/2000 mg metformin. 

Contraindication